Global Urapidil Market Growth (Status and Outlook) 2025-2031

September 2025 | 102 pages | ID: GC5D5297EFEEEN
LP Information

Abstracts

According to this study, the global Urapidil market size will reach US$ million by 2031.

United States market for Urapidil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Urapidil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Urapidil is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Urapidil players cover Takeda, Sanwa Kagaku Kenkyusho, AbbVie, Kaken Pharm, Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Urapidil Industry Forecast” looks at past sales and reviews total world Urapidil sales in 2024, providing a comprehensive analysis by region and market sector of projected Urapidil sales for 2025 through 2031. With Urapidil sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Urapidil industry.

This Insight Report provides a comprehensive analysis of the global Urapidil landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Urapidil portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Urapidil market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Urapidil and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Urapidil.

This report presents a comprehensive overview, market shares, and growth opportunities of Urapidil market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Injection
• Tablets

Segmentation by Application:

• Severe Hypertension And Refractory Hypertension
• Control Perioperative Hypertension
• Essential Hypertension
• Renal Hypertension
• High Blood Pressure Caused By Pheochromocytoma
• Congestive Heart Failure
• Dysuria
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Takeda
• Sanwa Kagaku Kenkyusho
• AbbVie
• Kaken Pharm
• Abbott
• Huayu (Wuxi) Pharmaceutical
• Shandong Luoxin Pharmaceutical Group
• Guangzhou Wanzheng Pharmaceutical
• Hebei Yipin Pharmaceutical
• Xi'an Lijun Pharmaceutical
• Tonghua Jinma Pharmaceutical Group
• Changchun Tiancheng Pharmaceutical
• Heilongjiang Fuhe Pharmaceutical Group

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Urapidil Market Size (2020-2031)
  2.1.2 Urapidil Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Urapidil by Country/Region (2020, 2024 & 2031)
2.2 Urapidil Segment by Type
  2.2.1 Injection
  2.2.2 Tablets
2.3 Urapidil Market Size by Type
  2.3.1 Urapidil Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Urapidil Market Size Market Share by Type (2020-2025)
2.4 Urapidil Segment by Application
  2.4.1 Severe Hypertension And Refractory Hypertension
  2.4.2 Control Perioperative Hypertension
  2.4.3 Essential Hypertension
  2.4.4 Renal Hypertension
  2.4.5 High Blood Pressure Caused By Pheochromocytoma
  2.4.6 Congestive Heart Failure
  2.4.7 Dysuria
  2.4.8 Other
2.5 Urapidil Market Size by Application
  2.5.1 Urapidil Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Urapidil Market Size Market Share by Application (2020-2025)

3 URAPIDIL MARKET SIZE BY PLAYER

3.1 Urapidil Market Size Market Share by Player
  3.1.1 Global Urapidil Revenue by Player (2020-2025)
  3.1.2 Global Urapidil Revenue Market Share by Player (2020-2025)
3.2 Global Urapidil Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 URAPIDIL BY REGION

4.1 Urapidil Market Size by Region (2020-2025)
4.2 Global Urapidil Annual Revenue by Country/Region (2020-2025)
4.3 Americas Urapidil Market Size Growth (2020-2025)
4.4 APAC Urapidil Market Size Growth (2020-2025)
4.5 Europe Urapidil Market Size Growth (2020-2025)
4.6 Middle East & Africa Urapidil Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Urapidil Market Size by Country (2020-2025)
5.2 Americas Urapidil Market Size by Type (2020-2025)
5.3 Americas Urapidil Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Urapidil Market Size by Region (2020-2025)
6.2 APAC Urapidil Market Size by Type (2020-2025)
6.3 APAC Urapidil Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Urapidil Market Size by Country (2020-2025)
7.2 Europe Urapidil Market Size by Type (2020-2025)
7.3 Europe Urapidil Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Urapidil by Region (2020-2025)
8.2 Middle East & Africa Urapidil Market Size by Type (2020-2025)
8.3 Middle East & Africa Urapidil Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL URAPIDIL MARKET FORECAST

10.1 Global Urapidil Forecast by Region (2026-2031)
  10.1.1 Global Urapidil Forecast by Region (2026-2031)
  10.1.2 Americas Urapidil Forecast
  10.1.3 APAC Urapidil Forecast
  10.1.4 Europe Urapidil Forecast
  10.1.5 Middle East & Africa Urapidil Forecast
10.2 Americas Urapidil Forecast by Country (2026-2031)
  10.2.1 United States Market Urapidil Forecast
  10.2.2 Canada Market Urapidil Forecast
  10.2.3 Mexico Market Urapidil Forecast
  10.2.4 Brazil Market Urapidil Forecast
10.3 APAC Urapidil Forecast by Region (2026-2031)
  10.3.1 China Urapidil Market Forecast
  10.3.2 Japan Market Urapidil Forecast
  10.3.3 Korea Market Urapidil Forecast
  10.3.4 Southeast Asia Market Urapidil Forecast
  10.3.5 India Market Urapidil Forecast
  10.3.6 Australia Market Urapidil Forecast
10.4 Europe Urapidil Forecast by Country (2026-2031)
  10.4.1 Germany Market Urapidil Forecast
  10.4.2 France Market Urapidil Forecast
  10.4.3 UK Market Urapidil Forecast
  10.4.4 Italy Market Urapidil Forecast
  10.4.5 Russia Market Urapidil Forecast
10.5 Middle East & Africa Urapidil Forecast by Region (2026-2031)
  10.5.1 Egypt Market Urapidil Forecast
  10.5.2 South Africa Market Urapidil Forecast
  10.5.3 Israel Market Urapidil Forecast
  10.5.4 Turkey Market Urapidil Forecast
10.6 Global Urapidil Forecast by Type (2026-2031)
10.7 Global Urapidil Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Urapidil Forecast

11 KEY PLAYERS ANALYSIS

11.1 Takeda
  11.1.1 Takeda Company Information
  11.1.2 Takeda Urapidil Product Offered
  11.1.3 Takeda Urapidil Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Takeda Main Business Overview
  11.1.5 Takeda Latest Developments
11.2 Sanwa Kagaku Kenkyusho
  11.2.1 Sanwa Kagaku Kenkyusho Company Information
  11.2.2 Sanwa Kagaku Kenkyusho Urapidil Product Offered
  11.2.3 Sanwa Kagaku Kenkyusho Urapidil Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Sanwa Kagaku Kenkyusho Main Business Overview
  11.2.5 Sanwa Kagaku Kenkyusho Latest Developments
11.3 AbbVie
  11.3.1 AbbVie Company Information
  11.3.2 AbbVie Urapidil Product Offered
  11.3.3 AbbVie Urapidil Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 AbbVie Main Business Overview
  11.3.5 AbbVie Latest Developments
11.4 Kaken Pharm
  11.4.1 Kaken Pharm Company Information
  11.4.2 Kaken Pharm Urapidil Product Offered
  11.4.3 Kaken Pharm Urapidil Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Kaken Pharm Main Business Overview
  11.4.5 Kaken Pharm Latest Developments
11.5 Abbott
  11.5.1 Abbott Company Information
  11.5.2 Abbott Urapidil Product Offered
  11.5.3 Abbott Urapidil Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Abbott Main Business Overview
  11.5.5 Abbott Latest Developments
11.6 Huayu (Wuxi) Pharmaceutical
  11.6.1 Huayu (Wuxi) Pharmaceutical Company Information
  11.6.2 Huayu (Wuxi) Pharmaceutical Urapidil Product Offered
  11.6.3 Huayu (Wuxi) Pharmaceutical Urapidil Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Huayu (Wuxi) Pharmaceutical Main Business Overview
  11.6.5 Huayu (Wuxi) Pharmaceutical Latest Developments
11.7 Shandong Luoxin Pharmaceutical Group
  11.7.1 Shandong Luoxin Pharmaceutical Group Company Information
  11.7.2 Shandong Luoxin Pharmaceutical Group Urapidil Product Offered
  11.7.3 Shandong Luoxin Pharmaceutical Group Urapidil Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Shandong Luoxin Pharmaceutical Group Main Business Overview
  11.7.5 Shandong Luoxin Pharmaceutical Group Latest Developments
11.8 Guangzhou Wanzheng Pharmaceutical
  11.8.1 Guangzhou Wanzheng Pharmaceutical Company Information
  11.8.2 Guangzhou Wanzheng Pharmaceutical Urapidil Product Offered
  11.8.3 Guangzhou Wanzheng Pharmaceutical Urapidil Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Guangzhou Wanzheng Pharmaceutical Main Business Overview
  11.8.5 Guangzhou Wanzheng Pharmaceutical Latest Developments
11.9 Hebei Yipin Pharmaceutical
  11.9.1 Hebei Yipin Pharmaceutical Company Information
  11.9.2 Hebei Yipin Pharmaceutical Urapidil Product Offered
  11.9.3 Hebei Yipin Pharmaceutical Urapidil Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Hebei Yipin Pharmaceutical Main Business Overview
  11.9.5 Hebei Yipin Pharmaceutical Latest Developments
11.10 Xi'an Lijun Pharmaceutical
  11.10.1 Xi'an Lijun Pharmaceutical Company Information
  11.10.2 Xi'an Lijun Pharmaceutical Urapidil Product Offered
  11.10.3 Xi'an Lijun Pharmaceutical Urapidil Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Xi'an Lijun Pharmaceutical Main Business Overview
  11.10.5 Xi'an Lijun Pharmaceutical Latest Developments
11.11 Tonghua Jinma Pharmaceutical Group
  11.11.1 Tonghua Jinma Pharmaceutical Group Company Information
  11.11.2 Tonghua Jinma Pharmaceutical Group Urapidil Product Offered
  11.11.3 Tonghua Jinma Pharmaceutical Group Urapidil Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Tonghua Jinma Pharmaceutical Group Main Business Overview
  11.11.5 Tonghua Jinma Pharmaceutical Group Latest Developments
11.12 Changchun Tiancheng Pharmaceutical
  11.12.1 Changchun Tiancheng Pharmaceutical Company Information
  11.12.2 Changchun Tiancheng Pharmaceutical Urapidil Product Offered
  11.12.3 Changchun Tiancheng Pharmaceutical Urapidil Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Changchun Tiancheng Pharmaceutical Main Business Overview
  11.12.5 Changchun Tiancheng Pharmaceutical Latest Developments
11.13 Heilongjiang Fuhe Pharmaceutical Group
  11.13.1 Heilongjiang Fuhe Pharmaceutical Group Company Information
  11.13.2 Heilongjiang Fuhe Pharmaceutical Group Urapidil Product Offered
  11.13.3 Heilongjiang Fuhe Pharmaceutical Group Urapidil Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Heilongjiang Fuhe Pharmaceutical Group Main Business Overview
  11.13.5 Heilongjiang Fuhe Pharmaceutical Group Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Urapidil Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Urapidil Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players ofTablets
Table 5. Urapidil Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Urapidil Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Urapidil Market Size Market Share by Type (2020-2025)
Table 8. Urapidil Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Urapidil Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Urapidil Market Size Market Share by Application (2020-2025)
Table 11. Global Urapidil Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Urapidil Revenue Market Share by Player (2020-2025)
Table 13. Urapidil Key Players Head office and Products Offered
Table 14. Urapidil Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Urapidil Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Urapidil Market Size Market Share by Region (2020-2025)
Table 19. Global Urapidil Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Urapidil Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Urapidil Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Urapidil Market Size Market Share by Country (2020-2025)
Table 23. Americas Urapidil Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Urapidil Market Size Market Share by Type (2020-2025)
Table 25. Americas Urapidil Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Urapidil Market Size Market Share by Application (2020-2025)
Table 27. APAC Urapidil Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Urapidil Market Size Market Share by Region (2020-2025)
Table 29. APAC Urapidil Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Urapidil Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Urapidil Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Urapidil Market Size Market Share by Country (2020-2025)
Table 33. Europe Urapidil Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Urapidil Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Urapidil Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Urapidil Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Urapidil Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Urapidil
Table 39. Key Market Challenges & Risks of Urapidil
Table 40. Key Industry Trends of Urapidil
Table 41. Global Urapidil Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Urapidil Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Urapidil Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Urapidil Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Takeda Details, Company Type, Urapidil Area Served and Its Competitors
Table 46. Takeda Urapidil Product Offered
Table 47. Takeda Urapidil Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Takeda Main Business
Table 49. Takeda Latest Developments
Table 50. Sanwa Kagaku Kenkyusho Details, Company Type, Urapidil Area Served and Its Competitors
Table 51. Sanwa Kagaku Kenkyusho Urapidil Product Offered
Table 52. Sanwa Kagaku Kenkyusho Urapidil Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Sanwa Kagaku Kenkyusho Main Business
Table 54. Sanwa Kagaku Kenkyusho Latest Developments
Table 55. AbbVie Details, Company Type, Urapidil Area Served and Its Competitors
Table 56. AbbVie Urapidil Product Offered
Table 57. AbbVie Urapidil Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. AbbVie Main Business
Table 59. AbbVie Latest Developments
Table 60. Kaken Pharm Details, Company Type, Urapidil Area Served and Its Competitors
Table 61. Kaken Pharm Urapidil Product Offered
Table 62. Kaken Pharm Urapidil Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Kaken Pharm Main Business
Table 64. Kaken Pharm Latest Developments
Table 65. Abbott Details, Company Type, Urapidil Area Served and Its Competitors
Table 66. Abbott Urapidil Product Offered
Table 67. Abbott Urapidil Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Abbott Main Business
Table 69. Abbott Latest Developments
Table 70. Huayu (Wuxi) Pharmaceutical Details, Company Type, Urapidil Area Served and Its Competitors
Table 71. Huayu (Wuxi) Pharmaceutical Urapidil Product Offered
Table 72. Huayu (Wuxi) Pharmaceutical Urapidil Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Huayu (Wuxi) Pharmaceutical Main Business
Table 74. Huayu (Wuxi) Pharmaceutical Latest Developments
Table 75. Shandong Luoxin Pharmaceutical Group Details, Company Type, Urapidil Area Served and Its Competitors
Table 76. Shandong Luoxin Pharmaceutical Group Urapidil Product Offered
Table 77. Shandong Luoxin Pharmaceutical Group Urapidil Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Shandong Luoxin Pharmaceutical Group Main Business
Table 79. Shandong Luoxin Pharmaceutical Group Latest Developments
Table 80. Guangzhou Wanzheng Pharmaceutical Details, Company Type, Urapidil Area Served and Its Competitors
Table 81. Guangzhou Wanzheng Pharmaceutical Urapidil Product Offered
Table 82. Guangzhou Wanzheng Pharmaceutical Urapidil Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Guangzhou Wanzheng Pharmaceutical Main Business
Table 84. Guangzhou Wanzheng Pharmaceutical Latest Developments
Table 85. Hebei Yipin Pharmaceutical Details, Company Type, Urapidil Area Served and Its Competitors
Table 86. Hebei Yipin Pharmaceutical Urapidil Product Offered
Table 87. Hebei Yipin Pharmaceutical Urapidil Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Hebei Yipin Pharmaceutical Main Business
Table 89. Hebei Yipin Pharmaceutical Latest Developments
Table 90. Xi'an Lijun Pharmaceutical Details, Company Type, Urapidil Area Served and Its Competitors
Table 91. Xi'an Lijun Pharmaceutical Urapidil Product Offered
Table 92. Xi'an Lijun Pharmaceutical Urapidil Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Xi'an Lijun Pharmaceutical Main Business
Table 94. Xi'an Lijun Pharmaceutical Latest Developments
Table 95. Tonghua Jinma Pharmaceutical Group Details, Company Type, Urapidil Area Served and Its Competitors
Table 96. Tonghua Jinma Pharmaceutical Group Urapidil Product Offered
Table 97. Tonghua Jinma Pharmaceutical Group Urapidil Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Tonghua Jinma Pharmaceutical Group Main Business
Table 99. Tonghua Jinma Pharmaceutical Group Latest Developments
Table 100. Changchun Tiancheng Pharmaceutical Details, Company Type, Urapidil Area Served and Its Competitors
Table 101. Changchun Tiancheng Pharmaceutical Urapidil Product Offered
Table 102. Changchun Tiancheng Pharmaceutical Urapidil Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Changchun Tiancheng Pharmaceutical Main Business
Table 104. Changchun Tiancheng Pharmaceutical Latest Developments
Table 105. Heilongjiang Fuhe Pharmaceutical Group Details, Company Type, Urapidil Area Served and Its Competitors
Table 106. Heilongjiang Fuhe Pharmaceutical Group Urapidil Product Offered
Table 107. Heilongjiang Fuhe Pharmaceutical Group Urapidil Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Heilongjiang Fuhe Pharmaceutical Group Main Business
Table 109. Heilongjiang Fuhe Pharmaceutical Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Urapidil Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Urapidil Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Urapidil Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Urapidil Sales Market Share by Country/Region (2024)
Figure 8. Urapidil Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Urapidil Market Size Market Share by Type in 2024
Figure 10. Urapidil in Severe Hypertension And Refractory Hypertension
Figure 11. Global Urapidil Market: Severe Hypertension And Refractory Hypertension (2020-2025) & ($ millions)
Figure 12. Urapidil in Control Perioperative Hypertension
Figure 13. Global Urapidil Market: Control Perioperative Hypertension (2020-2025) & ($ millions)
Figure 14. Urapidil in Essential Hypertension
Figure 15. Global Urapidil Market: Essential Hypertension (2020-2025) & ($ millions)
Figure 16. Urapidil in Renal Hypertension
Figure 17. Global Urapidil Market: Renal Hypertension (2020-2025) & ($ millions)
Figure 18. Urapidil in High Blood Pressure Caused By Pheochromocytoma
Figure 19. Global Urapidil Market: High Blood Pressure Caused By Pheochromocytoma (2020-2025) & ($ millions)
Figure 20. Urapidil in Congestive Heart Failure
Figure 21. Global Urapidil Market: Congestive Heart Failure (2020-2025) & ($ millions)
Figure 22. Urapidil in Dysuria
Figure 23. Global Urapidil Market: Dysuria (2020-2025) & ($ millions)
Figure 24. Urapidil in Other
Figure 25. Global Urapidil Market: Other (2020-2025) & ($ millions)
Figure 26. Global Urapidil Market Size Market Share by Application in 2024
Figure 27. Global Urapidil Revenue Market Share by Player in 2024
Figure 28. Global Urapidil Market Size Market Share by Region (2020-2025)
Figure 29. Americas Urapidil Market Size 2020-2025 ($ millions)
Figure 30. APAC Urapidil Market Size 2020-2025 ($ millions)
Figure 31. Europe Urapidil Market Size 2020-2025 ($ millions)
Figure 32. Middle East & Africa Urapidil Market Size 2020-2025 ($ millions)
Figure 33. Americas Urapidil Value Market Share by Country in 2024
Figure 34. United States Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 35. Canada Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 36. Mexico Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 37. Brazil Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 38. APAC Urapidil Market Size Market Share by Region in 2024
Figure 39. APAC Urapidil Market Size Market Share by Type (2020-2025)
Figure 40. APAC Urapidil Market Size Market Share by Application (2020-2025)
Figure 41. China Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 42. Japan Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 43. South Korea Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 44. Southeast Asia Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 45. India Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 46. Australia Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 47. Europe Urapidil Market Size Market Share by Country in 2024
Figure 48. Europe Urapidil Market Size Market Share by Type (2020-2025)
Figure 49. Europe Urapidil Market Size Market Share by Application (2020-2025)
Figure 50. Germany Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 51. France Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 52. UK Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 53. Italy Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 54. Russia Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 55. Middle East & Africa Urapidil Market Size Market Share by Region (2020-2025)
Figure 56. Middle East & Africa Urapidil Market Size Market Share by Type (2020-2025)
Figure 57. Middle East & Africa Urapidil Market Size Market Share by Application (2020-2025)
Figure 58. Egypt Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 59. South Africa Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 60. Israel Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 61. Turkey Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 62. GCC Countries Urapidil Market Size Growth 2020-2025 ($ millions)
Figure 63. Americas Urapidil Market Size 2026-2031 ($ millions)
Figure 64. APAC Urapidil Market Size 2026-2031 ($ millions)
Figure 65. Europe Urapidil Market Size 2026-2031 ($ millions)
Figure 66. Middle East & Africa Urapidil Market Size 2026-2031 ($ millions)
Figure 67. United States Urapidil Market Size 2026-2031 ($ millions)
Figure 68. Canada Urapidil Market Size 2026-2031 ($ millions)
Figure 69. Mexico Urapidil Market Size 2026-2031 ($ millions)
Figure 70. Brazil Urapidil Market Size 2026-2031 ($ millions)
Figure 71. China Urapidil Market Size 2026-2031 ($ millions)
Figure 72. Japan Urapidil Market Size 2026-2031 ($ millions)
Figure 73. Korea Urapidil Market Size 2026-2031 ($ millions)
Figure 74. Southeast Asia Urapidil Market Size 2026-2031 ($ millions)
Figure 75. India Urapidil Market Size 2026-2031 ($ millions)
Figure 76. Australia Urapidil Market Size 2026-2031 ($ millions)
Figure 77. Germany Urapidil Market Size 2026-2031 ($ millions)
Figure 78. France Urapidil Market Size 2026-2031 ($ millions)
Figure 79. UK Urapidil Market Size 2026-2031 ($ millions)
Figure 80. Italy Urapidil Market Size 2026-2031 ($ millions)
Figure 81. Russia Urapidil Market Size 2026-2031 ($ millions)
Figure 82. Egypt Urapidil Market Size 2026-2031 ($ millions)
Figure 83. South Africa Urapidil Market Size 2026-2031 ($ millions)
Figure 84. Israel Urapidil Market Size 2026-2031 ($ millions)
Figure 85. Turkey Urapidil Market Size 2026-2031 ($ millions)
Figure 86. Global Urapidil Market Size Market Share Forecast by Type (2026-2031)
Figure 87. Global Urapidil Market Size Market Share Forecast by Application (2026-2031)
Figure 88. GCC Countries Urapidil Market Size 2026-2031 ($ millions)